Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study.

Source:http://linkedlifedata.com/resource/pubmed/id/20648558

Int. J. Cancer 2011 May 15 128 10 2453-62

Download in:

View as

General Info

PMID
20648558